Use of 12-Month Renal Function and Baseline Clinical Factors to Predict Long-Term Graft Survival

Abstract

Accurate models of long-term graft survival can be developed using eGFR, donor, and recipient characteristics. Long-term survival prediction models may provide an efficient method for assessing the impact of novel pharmaceutical agents and clinical management protocols.

References

Page 1

	Year	Citations
Prediction of Coronary Heart Disease Using Risk Factor Categories Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy, Circulation	1998	9.5K
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto, Kidney International GlomerulonephritisHemodialysisRenal FunctionRenal DiseaseHealth Policy	2005	3.9K
Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era Herwig‐Ulf Meier‐Kriesche, Jesse D. Schold, Titte R. Srinivas, American Journal of Transplantation	2004	1.3K
Contributions to the problem of approximation of equidistant data by analytic functions. Part A. On the problem of smoothing or graduation. A first class of analytic approximation formulae I. J. Schoenberg Quarterly of Applied Mathematics Pade ApproximantEngineeringApproximation MethodAnalytic Approximation FormulaeAnalytic Functions	1946	927
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal Kenneth Lamb, Sundus A. Lodhi, H.-U. Meier-Kriesche American Journal of Transplantation UrologyTransplantationCritical ReappraisalKidney TransplantKidney Transplantation	2010	901
Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors1 Friedrich K. Port, Jennifer L. Bragg‐Gresham, Robert A. Metzger, Transplantation	2002	787
Identifying Specific Causes of Kidney Allograft Loss Ziad Zoghby, Mark D. Stegall, Donna J. Lager, American Journal of Transplantation	2009	782
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial Francesco Paolo Schena, M.D. Pascoe, Josefina Alberú, Transplantation	2009	574
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study) Antoine Dürrbach, JO Medina Pestana, Thomas C. Pearson, American Journal of Transplantation UrologyTransplantationCriteria DonorsKidney TransplantMedicine	2010	555
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study Yvon Lebranchu, Antoine Thierry, Olivier Toupance, American Journal of Transplantation	2009	258

Page 1